Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

NCT: NCT03906253 · RECRUITING

NCT IDNCT03906253
StatusRECRUITING
Start Date2018-01-10
Completion2028-12
SponsorWright State University (OTHER)
First posted
Last updated

Brief Summary

This study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) restores the appropriate UVB response. Ongoing studies have tested the ability of fractionated laser resurfacing (FLR) to assess how long this wounding effect lasts-and have found that this appears to be a durable response which lasts for at least two years. The findings that FLR protects geriatric skin at two years is the impetus for this study. This study is an interventional study to assess if FLR treatment of one forearm of geriatric subjects with multiple actinic keratosis will result in the short-term removal of actinic keratosis, and the long-term decrease in levels of future actinic keratosis and other non-melanoma skin cancers in comparison to the untreated arm. Study length and visit: The first part of the study is completed in 1 day then there are follow up visits at 90 days and every 6 months for 5 years.

Frequently Asked Questions

What is Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia?

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia is a clinical trial registered under NCT03906253. Current status: RECRUITING.

What is the status of NCT03906253?

The current status of NCT03906253 (Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia) is: RECRUITING.

When did Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia start?

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia started on 2018-01-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.